Journal articles on the topic 'Recombinant vaccine'
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Consult the top 50 journal articles for your research on the topic 'Recombinant vaccine.'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.
van Diepen, Michiel, Rosamund Chapman, Nicola Douglass, Leah Whittle, Nicole Chineka, Shireen Galant, Christian Cotchobos, Akiko Suzuki, and Anna-Lise Williamson. "Advancements in the Growth and Construction of Recombinant Lumpy Skin Disease Virus (LSDV) for Use as a Vaccine Vector." Vaccines 9, no. 10 (October 4, 2021): 1131. http://dx.doi.org/10.3390/vaccines9101131.
Full textCuervo, Nancy Stella, Sophie Guillot, Natalia Romanenkova, Mariana Combiescu, André Aubert-Combiescu, Mohamed Seghier, Valérie Caro, Radu Crainic, and Francis Delpeyroux. "Genomic Features of Intertypic Recombinant Sabin Poliovirus Strains Excreted by Primary Vaccinees." Journal of Virology 75, no. 13 (July 1, 2001): 5740–51. http://dx.doi.org/10.1128/jvi.75.13.5740-5751.2001.
Full textErtl, H. C., and Z. Xiang. "Novel vaccine approaches." Journal of Immunology 156, no. 10 (May 15, 1996): 3579–82. http://dx.doi.org/10.4049/jimmunol.156.10.3579.
Full textMarra, Yasmin, and Fawziah Lalji. "Prevention of Herpes Zoster: A Focus on the Effectiveness and Safety of Herpes Zoster Vaccines." Viruses 14, no. 12 (November 29, 2022): 2667. http://dx.doi.org/10.3390/v14122667.
Full textHudu, Shuaibu Abdullahi, Saadatu Haruna Shinkafi, and Shuaibu Umar. "AN OVERVIEW OF RECOMBINANT VACCINE TECHNOLOGY, ADJUVANTS AND VACCINE DELIVERY METHODS." International Journal of Pharmacy and Pharmaceutical Sciences 8, no. 11 (October 28, 2016): 19. http://dx.doi.org/10.22159/ijpps.2016v8i11.14311.
Full textWu, Xiao-Xin, Hang-Ping Yao, Nan-Ping Wu, Hai-Nv Gao, Hai-Bo Wu, Chang-Zhong Jin, Xiang-Yun Lu, Tian-Shen Xie, and Lan-Juan Li. "Ebolavirus Vaccines: Progress in the Fight Against Ebola Virus Disease." Cellular Physiology and Biochemistry 37, no. 5 (2015): 1641–58. http://dx.doi.org/10.1159/000438531.
Full textKoeberling, Oliver, Isabel Delany, and Dan M. Granoff. "A Critical Threshold of Meningococcal Factor H Binding Protein Expression Is Required for Increased Breadth of Protective Antibodies Elicited by Native Outer Membrane Vesicle Vaccines." Clinical and Vaccine Immunology 18, no. 5 (March 2, 2011): 736–42. http://dx.doi.org/10.1128/cvi.00542-10.
Full textSchlom, Jeffrey. "Recombinant cancer vaccines and new vaccine targets." Expert Review of Vaccines 12, no. 10 (October 2013): 1121–24. http://dx.doi.org/10.1586/14760584.2013.836913.
Full textStover, C. Kendall. "Recombinant vaccine delivery systems and encoded vaccines." Current Opinion in Immunology 6, no. 4 (August 1994): 568–71. http://dx.doi.org/10.1016/0952-7915(94)90143-0.
Full textDewidar, Abdelmonem A. A., Walid H. Kilany, Azza A. El-Sawah, Salama A. S. Shany, Al-Hussien M. Dahshan, Islam Hisham, Magdy F. Elkady, and Ahmed Ali. "Genotype VII.1.1-Based Newcastle Disease Virus Vaccines Afford Better Protection against Field Isolates in Commercial Broiler Chickens." Animals 12, no. 13 (June 30, 2022): 1696. http://dx.doi.org/10.3390/ani12131696.
Full textBaldo, Aline, Amaya Leunda, Nicolas Willemarck, and Katia Pauwels. "Environmental Risk Assessment of Recombinant Viral Vector Vaccines against SARS-Cov-2." Vaccines 9, no. 5 (May 3, 2021): 453. http://dx.doi.org/10.3390/vaccines9050453.
Full textGorse, Geoffrey J., Ramona E. Simionescu, and Gira B. Patel. "Cellular Immune Responses in Asymptomatic Human Immunodeficiency Virus Type 1 (HIV-1) Infection and Effects of Vaccination with Recombinant Envelope Glycoprotein of HIV-1." Clinical and Vaccine Immunology 13, no. 1 (January 2006): 26–32. http://dx.doi.org/10.1128/cvi.13.1.26-32.2006.
Full textWeaver, Eric A. "Dose Effects of Recombinant Adenovirus Immunization in Rodents." Vaccines 7, no. 4 (October 10, 2019): 144. http://dx.doi.org/10.3390/vaccines7040144.
Full textShollenberger, Lisa, Rafaella Grenfell, E. Farah Samli, and Donald Harn. "Vaccine self-assembling immune matrix (VacSIM) is a non-viral delivery platform that augments responses to recombinant protein vaccines (VAC6P.940)." Journal of Immunology 192, no. 1_Supplement (May 1, 2014): 140.1. http://dx.doi.org/10.4049/jimmunol.192.supp.140.1.
Full textHongying, Fan, Wu Xianbo, Yu Fang, Bai Yang, and Long Beiguo. "Oral Immunization with Recombinant Lactobacillus acidophilus Expressing the Adhesin Hp0410 of Helicobacter pylori Induces Mucosal and Systemic Immune Responses." Clinical and Vaccine Immunology 21, no. 2 (November 27, 2013): 126–32. http://dx.doi.org/10.1128/cvi.00434-13.
Full textYan, Lin, Jin Qiu, Jianbo Chen, Bridgett Ryan-Payseur, Dan Huang, Yunqi Wang, Lijun Rong, Jody A. Melton-Witt, Nancy E. Freitag, and Zheng W. Chen. "Selected prfA* Mutations in Recombinant Attenuated Listeria monocytogenes Strains Augment Expression of Foreign Immunogens and Enhance Vaccine-Elicited Humoral and Cellular Immune Responses." Infection and Immunity 76, no. 8 (May 12, 2008): 3439–50. http://dx.doi.org/10.1128/iai.00245-08.
Full textChang, Pengxiang, Faisal Ameen, Joshua E. Sealy, Jean-Remy Sadeyen, Sushant Bhat, Yongqing Li, and Munir Iqbal. "Application of HDR-CRISPR/Cas9 and Erythrocyte Binding for Rapid Generation of Recombinant Turkey Herpesvirus-Vectored Avian Influenza Virus Vaccines." Vaccines 7, no. 4 (November 22, 2019): 192. http://dx.doi.org/10.3390/vaccines7040192.
Full textShahriari, Amir Ghaffar, and Maziar Habibi-Pirkoohi. "Plant-Based Recombinant Vaccine: Fact or Fiction?" Galen Medical Journal 6, no. 4 (December 29, 2017): 268–80. http://dx.doi.org/10.31661/gmj.v6i4.792.
Full textPastoret, P. P., D. Boulanger, and B. Brochier. "Field trials of a recombinant rabies vaccine." Parasitology 110, S1 (March 1995): S37—S42. http://dx.doi.org/10.1017/s0031182000001475.
Full textBerg, Michael G., Robert J. Adams, Ratish Gambhira, Mark C. Siracusa, Alan L. Scott, Richard B. S. Roden, and Gary Ketner. "Immune Responses in Macaques to a Prototype Recombinant Adenovirus Live Oral Human Papillomavirus 16 Vaccine." Clinical and Vaccine Immunology 21, no. 9 (July 2, 2014): 1224–31. http://dx.doi.org/10.1128/cvi.00197-14.
Full textMcAllister, Andrés, Alejandra E. Arbetman, Stefanie Mandl, Claudia Peña-Rossi, and Raul Andino. "Recombinant Yellow Fever Viruses Are Effective Therapeutic Vaccines for Treatment of Murine Experimental Solid Tumors and Pulmonary Metastases." Journal of Virology 74, no. 19 (October 1, 2000): 9197–205. http://dx.doi.org/10.1128/jvi.74.19.9197-9205.2000.
Full textDAČIĆ, M., R. RESANOVIC, Z. RASIC, M. VALCIC, A. MILOVANOVIC, and M. VELHNER. "Efficacy of recombinant VAXXITEK HVT-IBDv vaccine against very virulent Infectious bursal disease virus (vvIBDv) challenge in layer chicks: A pilot study." Journal of the Hellenic Veterinary Medical Society 69, no. 1 (May 2, 2018): 823. http://dx.doi.org/10.12681/jhvms.16434.
Full textPearl, Karlyn K., Ana A. Ortiz, and William Pearl. "Efficacy of Immunization with a Combination of Serum and Recombinant Hepatitis B Vaccines." Infection Control & Hospital Epidemiology 14, no. 8 (August 1993): 476–78. http://dx.doi.org/10.1086/646783.
Full textCuccui, Jon, Rebecca M. Thomas, Madeleine G. Moule, Riccardo V. D'Elia, Thomas R. Laws, Dominic C. Mills, Diane Williamson, Timothy P. Atkins, Joann L. Prior, and Brendan W. Wren. "Exploitation of bacterial N -linked glycosylation to develop a novel recombinant glycoconjugate vaccine against Francisella tularensis." Open Biology 3, no. 5 (May 2013): 130002. http://dx.doi.org/10.1098/rsob.130002.
Full textWilladsen, P., P. Bird, G. S. Cobon, and J. Hungerford. "Commercialisation of a recombinant vaccine againstBoophilus microplus." Parasitology 110, S1 (March 1995): S43—S50. http://dx.doi.org/10.1017/s0031182000001487.
Full textSarmadi, Mahdieh, Azam Gheibi, Hossein Khanahmad, Mohammad Reza Khorramizadeh, Seyed Hossein Hejazi, Noushin Zahedi, Hamidreza Mianesaz, and Khosrow Kashfi. "Design and Characterization of a Recombinant Brucella abortus RB51 Vaccine That Elicits Enhanced T Cell-Mediated Immune Response." Vaccines 10, no. 3 (March 3, 2022): 388. http://dx.doi.org/10.3390/vaccines10030388.
Full textTang, Na, Yaoyao Zhang, Yashar Sadigh, Katy Moffat, Zhiqiang Shen, Venugopal Nair, and Yongxiu Yao. "Generation of A Triple Insert Live Avian Herpesvirus Vectored Vaccine Using CRISPR/Cas9-Based Gene Editing." Vaccines 8, no. 1 (February 21, 2020): 97. http://dx.doi.org/10.3390/vaccines8010097.
Full textTarcha, Eric J., Venkatesha Basrur, Chiung-Yu Hung, Malcolm J. Gardner, and Garry T. Cole. "Multivalent Recombinant Protein Vaccine against Coccidioidomycosis." Infection and Immunity 74, no. 10 (October 2006): 5802–13. http://dx.doi.org/10.1128/iai.00961-06.
Full textBarouch, Dan H., Paul F. McKay, Shawn M. Sumida, Sampa Santra, Shawn S. Jackson, Darci A. Gorgone, Michelle A. Lifton, et al. "Plasmid Chemokines and Colony-Stimulating Factors Enhance the Immunogenicity of DNA Priming-Viral Vector Boosting Human Immunodeficiency Virus Type 1 Vaccines." Journal of Virology 77, no. 16 (August 15, 2003): 8729–35. http://dx.doi.org/10.1128/jvi.77.16.8729-8735.2003.
Full textKumar, Pawan, Tamer A. Sharafeldin, Rahul Kumar, Qinfeng Huang, Yuying Liang, Sagar M. Goyal, Robert E. Porter, Hinh Ly, and Sunil K. Mor. "Development of a Recombinant Pichinde Virus-Vectored Vaccine against Turkey Arthritis Reovirus and Its Immunological Response Characterization in Vaccinated Animals." Pathogens 10, no. 2 (February 13, 2021): 197. http://dx.doi.org/10.3390/pathogens10020197.
Full textKrasilnikov, I. V., T. I. Vinogradova, M. Djonovic, N. V. Zabolotnykh, S. A. Arakelov, M. Z. Dogonadze, and V. G. Lunin. "TB skin test recombinant proteins as vaccine candidates." Genes & Cells 17, no. 2 (September 25, 2022): 47–55. http://dx.doi.org/10.23868/202209007.
Full textRizqoh, Debie. "Genetic Engineering Technique in Virus-Like Particle Vaccine Construction." Jurnal Kesehatan Masyarakat Indonesia 16, no. 4 (December 31, 2021): 203. http://dx.doi.org/10.26714/jkmi.16.4.2021.203-211.
Full textNoyce, Ryan S., Landon W. Westfall, Siobhan Fogarty, Karen Gilbert, Onesmo Mpanju, Helen Stillwell, José Esparza, et al. "Single Dose of Recombinant Chimeric Horsepox Virus (TNX-801) Vaccination Protects Macaques from Lethal Monkeypox Challenge." Viruses 15, no. 2 (January 26, 2023): 356. http://dx.doi.org/10.3390/v15020356.
Full textOurmanov, Ilnour, Charles R. Brown, Bernard Moss, Miles Carroll, Linda Wyatt, Liuobov Pletneva, Simoy Goldstein, David Venzon, and Vanessa M. Hirsch. "Comparative Efficacy of Recombinant Modified Vaccinia Virus Ankara Expressing Simian Immunodeficiency Virus (SIV) Gag-Pol and/or Env in Macaques Challenged with Pathogenic SIV." Journal of Virology 74, no. 6 (March 15, 2000): 2740–51. http://dx.doi.org/10.1128/jvi.74.6.2740-2751.2000.
Full textTseng, Ta-Yuan, Yee-Chen Liu, Yu-Chen Hsu, Poa-Chun Chang, Ming-Kun Hsieh, Jui-Hung Shien, and Shan-Chia Ou. "Preparation of Chicken Anemia Virus (CAV) Virus-Like Particles and Chicken Interleukin-12 for Vaccine Development Using a Baculovirus Expression System." Pathogens 8, no. 4 (November 23, 2019): 262. http://dx.doi.org/10.3390/pathogens8040262.
Full textKim, Joseph W., Jennifer L. Marte, Nishith K. Singh, Christopher Ryan Heery, Ravi Amrit Madan, Mary Pazdur, Sheri McMahon, et al. "Safety profile of recombinant poxviral TRICOM vaccines." Journal of Clinical Oncology 31, no. 15_suppl (May 20, 2013): e16036-e16036. http://dx.doi.org/10.1200/jco.2013.31.15_suppl.e16036.
Full text&NA;. "Hepatitis B vaccine recombinant." Reactions Weekly &NA;, no. 1378 (November 2011): 19. http://dx.doi.org/10.2165/00128415-201113780-00067.
Full text&NA;. "Hepatitis B vaccine recombinant." Reactions Weekly &NA;, no. 702 (May 1998): 7. http://dx.doi.org/10.2165/00128415-199807020-00016.
Full text&NA;. "Hepatitis B vaccine recombinant." Reactions Weekly &NA;, no. 708 (July 1998): 7. http://dx.doi.org/10.2165/00128415-199807080-00022.
Full text&NA;. "Hepatitis B vaccine recombinant." Reactions Weekly &NA;, no. 710 (July 1998): 8. http://dx.doi.org/10.2165/00128415-199807100-00025.
Full text&NA;. "Hepatitis B vaccine recombinant." Reactions Weekly &NA;, no. 714 (August 1998): 9. http://dx.doi.org/10.2165/00128415-199807140-00029.
Full text&NA;. "Hepatitis B vaccine recombinant." Reactions Weekly &NA;, no. 720 (September 1998): 8. http://dx.doi.org/10.2165/00128415-199807200-00018.
Full text&NA;. "Hepatitis B vaccine recombinant." Reactions Weekly &NA;, no. 722 (October 1998): 9. http://dx.doi.org/10.2165/00128415-199807220-00024.
Full text&NA;. "Hepatitis B vaccine recombinant." Reactions Weekly &NA;, no. 724 (October 1998): 8. http://dx.doi.org/10.2165/00128415-199807240-00024.
Full text&NA;. "Hepatitis B vaccine recombinant." Reactions Weekly &NA;, no. 727 (November 1998): 8. http://dx.doi.org/10.2165/00128415-199807270-00021.
Full text&NA;. "Hepatitis B vaccine recombinant." Reactions Weekly &NA;, no. 739 (February 1999): 9. http://dx.doi.org/10.2165/00128415-199907390-00028.
Full text&NA;. "Hepatitis B vaccine recombinant." Reactions Weekly &NA;, no. 741 (March 1999): 10. http://dx.doi.org/10.2165/00128415-199907410-00030.
Full text&NA;. "Hepatitis B vaccine recombinant." Reactions Weekly &NA;, no. 747 (April 1999): 7. http://dx.doi.org/10.2165/00128415-199907470-00019.
Full text&NA;. "Hepatitis B vaccine recombinant." Reactions Weekly &NA;, no. 1194-1195 (March 2008): 20. http://dx.doi.org/10.2165/00128415-200811940-00069.
Full text&NA;. "Hepatitis B vaccine recombinant." Reactions Weekly &NA;, no. 1139 (February 2007): 14. http://dx.doi.org/10.2165/00128415-200711390-00048.
Full text